Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | EGFR |
| Upstream (Parents) |
|---|
| (<<) ADAM9 → EGFR |
| (<<) ARHGEF2 → EGFR |
| (<<) ATF4 → EGFR |
| (<<) CRK → EGFR |
| (<<) EFNB2 → EGFR |
| (<<) ENO3 → EGFR |
| (<<) HDAC6 → EGFR |
| (<<) HK1 → EGFR |
| (<<) HNF1A → EGFR |
| (<<) KREMEN2 → EGFR |
| (<<) MCL1 → EGFR |
| (<<) MMP9 → EGFR |
| (<<) PDGFB → EGFR |
| (<<) PKM2 → EGFR |
| (<<) PRDX6 → EGFR |
| (<<) PSAT1 → EGFR |
| (<<) PTPRE → EGFR |
| (<<) SAA4 → EGFR |
| Downstream (Children) |
|---|
| EGFR → ATN1 (>>) |
| EGFR → CHPF (>>) |
| EGFR → CYP2U1 (>>) |
| EGFR → DYRK1A (>>) |
| EGFR → GLTPD1 (>>) |
| EGFR → IL1F5 (>>) |
| EGFR → NRN1 (>>) |
| EGFR → RAB5B (>>) |
| EGFR → SPDEF (>>) |
| EGFR → ZNF365 (>>) |
